Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin adjunct to insulin in cystic fibrosis-related diabetes
NL-OMON38078Phase 3Active, not recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Oct 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of metformin and human insulin in cystic fibrosis-related diabetes (CFRD) (2 arms), sponsored by HagaZiekenhuis. Primary endpoints: Insulin requirement and HbA1c. Started Oct 2009; status: active, not recruiting.
02
Drugs
metforminhuman insulin
03
Conditions
cystic fibrosis-related diabetes (CFRD)
Beyond the preview
Go deeper on NL-OMON38078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38078.